These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 33554316)
1. Elucidating the Splitting Behavior of Tablets to Optimize the Pharmacotherapy in Veterinary Medicine. Bedogni GR; Pires FQ; Chaker JA; Sa-Barreto LL; Seremeta K; Okulik N; Salomon CJ; Cunha-Filho M AAPS PharmSciTech; 2021 Feb; 22(2):67. PubMed ID: 33554316 [TBL] [Abstract][Full Text] [Related]
2. Impact of formulation variables on weight uniformity of scored tablets using factorial design. Zaid AN; Hawari R; Malkieh N; Natshih Y; Yousef A; Jaradat N; Hammad A; Basharat R Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2501-2507. PubMed ID: 31894042 [TBL] [Abstract][Full Text] [Related]
3. Compliance of scored tablet halves produced by Palestinian Pharmaceutical Companies with the new European Pharmacopoeia requirements. Zaid AN; Ghosh AA Arch Pharm Res; 2011 Jul; 34(7):1183-9. PubMed ID: 21811926 [TBL] [Abstract][Full Text] [Related]
4. Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium. Shah RB; Collier JS; Sayeed VA; Bryant A; Habib MJ; Khan MA AAPS PharmSciTech; 2010 Sep; 11(3):1359-67. PubMed ID: 20740332 [TBL] [Abstract][Full Text] [Related]
5. Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting. Helmy SA J Manag Care Spec Pharm; 2015 Jan; 21(1):76-86. PubMed ID: 25562775 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Discrepancy between the European Pharmacopoeia Test and an Adopted United States Pharmacopoeia Test Regarding the Weight Uniformity of Scored Tablet Halves: Is Harmonization Required? Zaid AN; Ghoush AA; Al-Ramahi R; Are'r M PDA J Pharm Sci Technol; 2012; 66(1):20-7. PubMed ID: 22307659 [TBL] [Abstract][Full Text] [Related]
7. Towards a real time release approach for manufacturing tablets using NIR spectroscopy. Pestieau A; Krier F; Thoorens G; Dupont A; Chavez PF; Ziemons E; Hubert P; Evrard B J Pharm Biomed Anal; 2014 Sep; 98():60-7. PubMed ID: 24880992 [TBL] [Abstract][Full Text] [Related]
8. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry. Ciavarella AB; Khan MA; Gupta A; Faustino PJ PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592 [TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical counselling about different types of tablet-splitting methods based on the results of weighing tests and mechanical development of splitting devices. Somogyi O; Meskó A; Csorba L; Szabó P; Zelkó R Eur J Pharm Sci; 2017 Aug; 106():262-273. PubMed ID: 28606803 [TBL] [Abstract][Full Text] [Related]
10. Applications of excipients in the field of 3D printed pharmaceuticals. Tian P; Yang F; Yu LP; Lin MM; Lin W; Lin QF; Lv ZF; Huang SY; Chen YZ Drug Dev Ind Pharm; 2019 Jun; 45(6):905-913. PubMed ID: 30744433 [TBL] [Abstract][Full Text] [Related]
11. Dependence of Friability on Tablet Mechanical Properties and a Predictive Approach for Binary Mixtures. Paul S; Sun CC Pharm Res; 2017 Dec; 34(12):2901-2909. PubMed ID: 28983779 [TBL] [Abstract][Full Text] [Related]
16. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets? Košir D; Ojsteršek T; Vrečer F Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075 [TBL] [Abstract][Full Text] [Related]
17. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets. Cook TJ; Edwards S; Gyemah C; Shah M; Shah I; Fox T J Am Pharm Assoc (2003); 2004; 44(5):583-6. PubMed ID: 15496044 [TBL] [Abstract][Full Text] [Related]
18. Assessment of Tablet Surface Hardness by Laser Ablation and Its Correlation With the Erosion Tendency of Core Tablets. Narang AS; Breckenridge L; Guo H; Wang J; Wolf AA; Desai D; Varia S; Badawy S J Pharm Sci; 2017 Jan; 106(1):200-207. PubMed ID: 27686683 [TBL] [Abstract][Full Text] [Related]